Daclizumab Use in Patients With Pediatric Multiple Sclerosis

Authors:

Abstract
BackgroundDaclizumab, a humanized monoclonal antibody specific for the interleukin 2 receptor α chain, reduces clinical and magnetic resonance imaging disease a

This publication has 16 references indexed in Scilit: